Promising MS Research to Repair, Protect and Restore the Nervous System. Moderator Kate Milliken and panelists Dr. Ben Barres, Dr. Jonah Chan, Dr. Timothy Coetzee and Dr. Rhonda Voskuhl. December 5, 2013

Large Phase 3 trials in RR MS. Updated September 2013. Abbreviations Key: AAN – American Academy of Neurology. CIS – Clinically Isolated Syndrome.

Clinical trials help to find solutions for everyone affected by MS. Find studies near you.

This presentation is: From Clinical Trials to Treatments.

This document outlines Symptomatic Treatment Trials.

Original Air Date: March 22, 2011 Presenter: Dr. Patricia O'Looney Research in MS is progressing at a remarkable rate, with more potential therapies in the pipeline than at any other time in history. The National MS Society is a driving force of MS research. Learn how far we've come, where we're going, and what the Society is doing to move toward a world free of MS.

Original Air Date: October 6, 2011

During this teleconference participants will: Understand the risks and benefits of different treatment options; Learn about new treatments on the horizon; Understand how different treatment options compare to each other. The speaker, Dr. Graesser, specializes in MS and in addition to general neurology cases, she also provides care for movement disorders, headaches, and neurologic disorders in pregnancy.

Neuro-opthalmologist Tariq Bhatti, MD, at Duke University Eye Center, discusses the use of optical coherence tomography (OCT) in evaluating multiple sclerosis (MS) progression and the effects of treatments - namely anti-LINGO-1.